Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 13, 2010
Event: Entry into a Material Definitive Agreement involving the issuance of a convertible promissory note to a board member.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, or general liquidity metrics. It discloses a specific new financial obligation:
- Principal Amount: $500,000
- Interest Rate: 5% per annum (increases to 10% per annum if not paid within three business days of maturity)
- Maturity Date: 90 days from issuance (approximately October 11, 2010)
- Security Status: Unsecured
- Counterparty: Kevin and Margaret Richardson (Kevin Richardson is a member of the Board of Directors)
Material Changes and Terms
The Company entered into a new debt instrument with the following material terms:
- Conversion Trigger: Upon a "Qualified Financing" (defined as a private placement of at least $3,000,000 in Common Stock), the unpaid principal and interest convert into Common Stock, a warrant for an equal number of shares, and any other securities issued in that financing.
- Default Warrant: If the Note is not paid or converted by the Maturity Date, the holder receives a warrant to purchase Common Stock at $4.00 per share. The number of shares is calculated by dividing the total principal and interest by 20.
- Penalty Provisions: If not paid in full within three business days of the Maturity Date, interest accrues at 10% per annum. The Company must also pay collection costs, including 15% of the principal and interest as attorneys' fees.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance or general management commentary beyond the terms of the agreement.
Risks and Contingencies:
- Liquidity Risk: The Company faces a cash outflow obligation of $500,000 plus accrued interest within 90 days unless a Qualified Financing is consummated.
- Dilution Risk: Failure to pay or convert triggers the issuance of warrants at a fixed price of $4.00, potentially diluting existing shareholders.
- Related Party Transaction: The debt is owed to a board member, requiring scrutiny of the terms relative to market rates and arm's-length standards.
Investor Verification Checklist
- Verify the Company's current cash position to assess ability to repay the $500,000 note by the maturity date.
- Confirm the status of any ongoing efforts to secure a "Qualified Financing" of at least $3,000,000 to trigger conversion rather than cash repayment.
- Review the Company's capitalization table to understand the potential dilution impact of the default warrant (shares = Total Debt / 20) or conversion terms.
- Check for any subsequent filings regarding the repayment, conversion, or extension of this specific note.